High-density lipoprotein phospholipids interfere with dendritic cell Th1 functional maturation

Immunobiology

Volumn 217, Issue 1, 2012, Pages 91-99

  Perrin Cocon, Laure ^a,b   Diaz, Olivier ^a,b   Carreras, Martine ^a,b   Dollet, Sandra ^a,b   Guironnet Paquet, Aurélie ^a,b,c   André, Patrice ^a,b,c   Lotteau, Vincent ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b INSERM   (France)

^c CROIX ROUSSE HOSPITAL   (France)

Author keywords

Atherosclerosis; Dendritic cell function; Immunomodulation; Lipoprotein; Th1 response

Indexed keywords

1 PALMITOYL 2 LINOLEYL PHOSPHATIDYLCHOLINE; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; TH1 CELL;

CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MONOCYTES; NF-KAPPA B; PHOSPHATIDYLCHOLINES; SIGNAL TRANSDUCTION; TH1 CELLS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 6;

EID: 82155167645     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.07.030     Document Type: Article

References (60)

1. Agaugue S., Perrin-Cocon L., Coutant F., Andre P., Lotteau V. 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity. J. Immunol. 2006, 177:2061-2071.
2. Agaugue S., Perrin-Cocon L., Andre P., Lotteau V. Hepatitis C lipo-viro-particle from chronically infected patients interferes with TLR4 signaling in dendritic cell. PLoS One 2007, 2:e330.
3. Al-Jarallah A., Trigatti B.L. A role for the scavenger receptor, class B type I in high density lipoprotein dependent activation of cellular signaling pathways. Biochim. Biophys. Acta 2010, 1801:1239-1248.
4. Angeli V., Llodra J., Rong J.X., Satoh K., Ishii S., Shimizu T., Fisher E.A., Randolph G.J. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 2004, 21:561-574.
5. Appel S., Mirakaj V., Bringmann A., Weck M.M., Grunebach F., Brossart P. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 2005, 106:3888-3894.
6. Areschoug T., Gordon S. Scavenger receptors: role in innate immunity and microbial pathogenesis. Cell Microbiol. 2009, 11:1160-1169.
7. Barter P. The inflammation: lipoprotein cycle. Atheroscler. Suppl. 2005, 6:15-20.
8. Coutant F., Perrin-Cocon L., Agaugue S., Delair T., Andre P., Lotteau V. Mature dendritic cell generation promoted by lysophosphatidylcholine. J. Immunol. 2002, 169:1688-1695.
9. Coutant F., Agaugue S., Perrin-Cocon L., Andre P., Lotteau V. Sensing environmental lipids by dendritic cell modulates its function. J. Immunol. 2004, 172:54-60.
10. Erridge C., Kennedy S., Spickett C.M., Webb D.J. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. J. Biol. Chem. 2008, 283:24748-24759.
11. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226:497-509.
12. Fournier N., Paul J.L., Atger V., Cogny A., Soni T., de la Llera-Moya M., Rothblat G., Moatti N. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler. Thromb. Vasc. Biol. 1997, 17:2685-2691.
13. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 1997, 99:2752-2761.
14. Hansson G.K., Holm J., Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 1989, 135:169-175.
15. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34:1345-1353.
16. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., Sovath S., Shamel L., Hartung T., Zahringer U., Beutler B. CD36 is a sensor of diacylglycerides. Nature 2005, 433:523-527.
17. Jahangiri A., de Beer M.C., Noffsinger V., Tannock L.R., Ramaiah C., Webb N.R., van der Westhuyzen D.R., de Beer F.C. HDL remodeling during the acute phase response. Arterioscler. Thromb. Vasc. Biol. 2009, 29:261-267.
18. Kates M. Techniques of lipidology: isolation, analysis, and identification of lipids. Laboratory Techniques in Biochemistry and Molecular Biology 1986, 232-254. Elsevier Science Ltd, New York. R. Burden, P. van Kippenburg (Eds.).
19. Kobayashi M., Saitoh S., Tanimura N., Takahashi K., Kawasaki K., Nishijima M., Fujimoto Y., Fukase K., Akashi-Takamura S., Miyake K. Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J. Immunol. 2006, 176:6211-6218.
20. Kume N., Cybulsky M.I., Gimbrone M.A. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 1992, 90:1138-1144.
21. Kzhyshkowska J., Krusell L. Cross-talk between endocytic clearance and secretion in macrophages. Immunobiology 2009, 214:576-593.
22. Laurat E., Poirier B., Tupin E., Caligiuri G., Hansson G.K., Bariety J., Nicoletti A. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 2001, 104:197-202.
23. Lee T.S., Yen H.C., Pan C.C., Chau L.Y. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 1999, 19:734-742.
24. Lewis G.F., Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 2005, 96:1221-1232.
25. Loscher C.E., Draper E., Leavy O., Kelleher D., Mills K.H., Roche H.M. Conjugated linoleic acid suppresses NF-kappa B activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J. Immunol. 2005, 175:4990-4998.
26. Mahley R.W., Rall S.C. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 2000, 1:507-537.
27. McMahon M., Grossman J., FitzGerald J., Dahlin-Lee E., Wallace D.J., Thong B.Y., Badsha H., Kalunian K., Charles C., Navab M., Fogelman A.M., Hahn B.H. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006, 54:2541-2549.
28. Murphy A.J., Woollard K.J., Hoang A., Mukhamedova N., Stirzaker R.A., McCormick S.P., Remaley A.T., Sviridov D., Chin-Dusting J. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol. 2008, 28:2071-2077.
29. Nagano H., Mitchell R.N., Taylor M.K., Hasegawa S., Tilney N.L., Libby P. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J. Clin. Invest. 1997, 100:550-557.
30. Navab M., Imes S.S., Hama S.Y., Hough G.P., Ross L.A., Bork R.W., Valente A.J., Berliner J.A., Drinkwater D.C., Laks H., et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 1991, 88:2039-2046.
31. Navab M., Reddy S.T., Van Lenten B.J., Anantharamaiah G.M., Fogelman A.M. The role of dysfunctional HDL in atherosclerosis. J. Lipid Res. 2009, 50(Suppl.):S145-S149.
32. Niessner A., Weyand C.M. Dendritic cells in atherosclerotic disease. Clin. Immunol. 2010, 134:25-32.
33. Norata G.D., Callegari E., Marchesi M., Chiesa G., Eriksson P., Catapano A.L. High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells. Circulation 2005, 111:2805-2811.
34. Parker L.C., Prestwich E.C., Ward J.R., Smythe E., Berry A., Triantafilou M., Triantafilou K., Sabroe I. A phosphatidylserine species inhibits a range of TLR- but not IL-1beta-induced inflammatory responses by disruption of membrane microdomains. J. Immunol. 2008, 181:5606-5617.
35. Perrin-Cocon L., Coutant F., Agaugue S., Deforges S., Andre P., Lotteau V. Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J. Immunol. 2001, 167:3785-3791.
36. Perrin-Cocon L., Agaugue S., Coutant F., Saint-Mezard P., Guironnet-Paquet A., Nicolas J.F., Andre P., Lotteau V. Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses. Vaccine 2006, 24:1254-1263.
37. Perrin-Cocon L., Agaugue S., Diaz O., Vanbervliet B., Dollet S., Guironnet-Paquet A., Andre P., Lotteau V. Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus. PLoS One 2008, 3:e2260.
38. Pruzanski W., Stefanski E., de Beer F.C., de Beer M.C., Ravandi A., Kuksis A. Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. J. Lipid Res. 2000, 41:1035-1047.
39. Puig-Kroger A., Relloso M., Fernandez-Capetillo O., Zubiaga A., Silva A., Bernabeu C., Corbi A.L. Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 2001, 98:2175-2182.
40. Raisanen-Sokolowski A., Glysing-Jensen T., Koglin J., Russell M.E. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. Am. J. Pathol. 1998, 152:359-365.
41. Randolph G.J., Beaulieu S., Lebecque S., Steinman R.M., Muller W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998, 282:480-483.
42. Saddar S., Mineo C., Shaul P.W. Signaling by the high-affinity HDL receptor scavenger receptor B type I. Arterioscler. Thromb. Vasc. Biol. 2010, 30:144-150.
43. Scanu A.M., Edelstein C. HDL: bridging past and present with a look at the future. FASEB J. 2008, 22:4044-4054.
44. Shamshiev A.T., Ampenberger F., Ernst B., Rohrer L., Marsland B.J., Kopf M. Dyslipidemia inhibits toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity. J. Exp. Med. 2007, 204:441-452.
45. Spirig R., van Kooten C., Obregon C., Nicod L., Daha M., Rieben R. The complement inhibitor low molecular weight dextran sulfate prevents TLR4-induced phenotypic and functional maturation of human dendritic cells. J. Immunol. 2008, 181:878-890.
46. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., Rayner K.J., Boyer L., Zhong R., Frazier W.A., Lacy-Hulbert A., El Khoury J., Golenbock D.T., Moore K.J. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 2010, 11:155-161.
47. Stuart L.M., Deng J., Silver J.M., Takahashi K., Tseng A.A., Hennessy E.J., Ezekowitz R.A., Moore K.J. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 2005, 170:477-485.
48. Sviridov D., Mukhamedova N., Remaley A.T., Chin-Dusting J., Nestel P. Antiatherogenic functionality of high density lipoprotein: how much versus how good. J. Atheroscler. Thromb. 2008, 15:52-62.
49. Takeda K., Akira S. TLR signaling pathways. Semin. Immunol. 2004, 16:3-9.
50. Triantafilou M., Brandenburg K., Kusumoto S., Fukase K., Mackie A., Seydel U., Triantafilou K. Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses. Biochem. J. 2004, 381:527-536.
51. van den Elzen P., Garg S., Leon L., Brigl M., Leadbetter E.A., Gumperz J.E., Dascher C.C., Cheng T.Y., Sacks F.M., Illarionov P.A., Besra G.S., Kent S.C., Moody D.B., Brenner M.B. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 2005, 437:906-910.
52. Van Lenten B.J., Hama S.Y., de Beer F.C., Stafforini D.M., McIntyre T.M., Prescott S.M., La Du B.N., Fogelman A.M., Navab M. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 1995, 96:2758-2767.
53. van Leuven S.I., Hezemans R., Levels J.H., Snoek S., Stokkers P.C., Hovingh G.K., Kastelein J.J., Stroes E.S., de Groot E., Hommes D.W. Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease. J. Lipid Res. 2007, 48:2640-2646.
54. Wadham C., Albanese N., Roberts J., Wang L., Bagley C.J., Gamble J.R., Rye K.A., Barter P.J., Vadas M.A., Xia P. High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation 2004, 109:2116-2122.
55. Walton K.A., Cole A.L., Yeh M., Subbanagounder G., Krutzik S.R., Modlin R.L., Lucas R.M., Nakai J., Smart E.J., Vora D.K., Berliner J.A. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1197-1203.
56. Walton K.A., Hsieh X., Gharavi N., Wang S., Wang G., Yeh M., Cole A.L., Berliner J.A. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 2003, 278:29661-29666.
57. Walton K.A., Gugiu B.G., Thomas M., Basseri R.J., Eliav D.R., Salomon R.G., Berliner J.A. A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products. J. Lipid Res. 2006, 47:1967-1974.
58. Wiesner P., Leidl K., Boettcher A., Schmitz G., Liebisch G. Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J. Lipid Res. 2009, 50:574-585.
59. Yu B.L., Wang S.H., Peng D.Q., Zhao S.P. HDL and immunomodulation: an emerging role of HDL against atherosclerosis. Immunol. Cell Biol. 2010, 88:285-290.
60. Zapata-Gonzalez F., Rueda F., Petriz J., Domingo P., Villarroya F., Diaz-Delfin J., de Madariaga M.A., Domingo J.C. Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids. J. Leukoc. Biol. 2008, 84:1172-1182.